BDMD Share Price Performance
US$2.04
-2.28 (-52.78%)
Price US$2.04
Share PriceUS$2.04
Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Might Not Be As Mispriced As It Looks After Plunging 43%
Jul 31
Baird Medical Investment Holdings Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
BDMD Community Narratives
There are no narratives available yet.
Baird Medical Investment Holdings Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.46
- Gross Margin
- 88.16%
- Net Profit Margin
- 33.62%
- Debt/Equity Ratio
- 51.5%
Baird Medical Investment Holdings Limited Competitors
Snowflake Analysis
About BDMD
- Founded
- 2012
- Employees
- 143
- CEO
- WebsiteView website
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.4%
- 1 Year: 24.1%
- Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. In the last year, the market has climbed 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›